Related Experiment Video
Updated: Apr 7, 2026

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
Published on: February 19, 2017
Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1
Leila Chaouch1, Miniar Kalai11, Imen Darragi1
1a Université de Tunis El Manar, Institut Pasteur de Tunis, Laboratoire d'Hématologie Moléculaire et Cellulaire , Tunis , Tunisie.
Insights
Children with sickle cell anemia (SCA) and specific gene variations in UGT1A1 and SLCO1A2 face a significantly higher risk of developing gallstones. This study highlights key genetic factors contributing to cholelithiasis in pediatric SCA patients.
Area of Science:
- Genetics
- Pediatrics
- Gastroenterology
Background:
- Hyperbilirubinemia in sickle cell anemia (SCA) can lead to pigment gallstones.
- Enzyme defects in bilirubin metabolism may exacerbate gallstone formation.
- Genetic polymorphisms in bilirubin metabolism genes are implicated.
Purpose of the Study:
- To investigate the correlation between specific gene polymorphisms and gallstone presence in Tunisian pediatric SCA patients.
- To analyze polymorphisms in SLCO1B1 (rs4149056), SLCO1A2 (rs4149000), and UGT1A1 (rs8175347, rs887829).
Main Methods:
- Study included 102 Tunisian pediatric SCA patients with hyperbilirubinemia.
- 52 patients had cholelithiasis; 50 did not.
- Gene polymorphisms analyzed via PCR/sequencing; frequencies compared using Pearson's chi-square test.
Main Results:
- Children with a combined genotype (TA7TA7)/TT/TC/GA showed a significantly higher risk of gallstones.
- This combined genotype was associated with an 18.27-fold increased risk (P=0.0027).
Conclusions:
- UGT1A1 and SLCO1A2 gene polymorphisms are implicated in the development of gallstones in SCA.
- Findings highlight the role of specific genetic variations in SCA-related cholelithiasis.
Aims And Background:
Hyperbilirubinemia is often observed in chronic hemolysis and results in the formation of pigment cholelithiasis that could be increased by the presence of defected enzymes involved in the bilirubin metabolism. Indeed, this is the first report that interested in the study of polymorphisms in genes encoded for enzymes involved in the bilirubin metabolism: rs 4149056 of SLCO1B1 and rs4149000 of SLCO1A2 in combination with rs8175347 and rs887829 of UGT1A1 in order to find a correlation between the polymorphisms studied and the presence of gallstones in a population of sickle cell anemia (SCA) pediatric Tunisians.
Material And Methods:
Our study involved 102 unrelated Tunisian subjects. All SCA patients are children (less than 16 years old) and were characterized by hyperbilirubinemia and 52 of them have cholelithiasis. The polymorphisms of the candidate genes were analyzed for all subjects by PCR/sequencing. Genotype and allele frequencies between cases and controls were compared using Pearson's chi-square test with a significance threshold of P < 0.05 (compare 2, version 1.02).
Results:
The novelty of this report is that children carrying the combined genotype of the rs studied: (TA7TA7)/TT/TC/GA have a higher risk to develop gallstones (P = 0.0027, RR = 18.27 (20.0061-915.28)).
Conclusion:
Altogether our data provide the implication of UGT1A1 and SLCO1A2 in sickle cell anemia-related cholelithiasis.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Pedigree Analysis
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Animal Mitochondrial Genetics
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

